INTERVIEW

Janus Electric funded for growth as global expansion gains momentum
09 June 2026 - Fresh funding and US momentum support Janus Electric's growth strategy

RFM’s Matt Mitchell charts Australia’s cotton future
01 June 2026 - Australia’s premium cotton - driven by our unique growing environment - underpins RFM’s expansion strategy in Central Queensland.

Chilwa Minerals expands Malawi laboratory operations through Lindian agreement
28 May 2026 - Lindian Resources has engaged Chilwa’s Zalewa laboratory to support drilling and sample preparation activities at Kangankunde

Immutep advances autoimmune program while reviewing efti pathway
18 May 2026 - Mark Voigt, CEO and Executive Director of Immutep, discusses the company’s strategic priorities following the discontinuation of its Phase III TACTI-004 lung cancer trial

Pure One Corporation positioned for growth in clean commercial transport
18 May 2026 - Trim Capital initiates coverage on Pure One Corporation, highlighting the company’s clean mobility platform and exposure to the growing electrification of heavy transport

Chilwa Minerals: Exploration advances as valuation lifted to A$1.83
05 May 2026 - Chilwa Minerals continues to progress exploration across its Lake Chilwa project while maintaining timelines for key development milestones and funding initiatives.

Senetas Corporation: Positioned for growth across global cybersecurity markets
31 Mar 2026 - Andrew Wilson, CEO of Senetas Corporation, outlines expanding international opportunities and long-term demand for encryption solutions.

Chilwa Minerals: Multi-commodity project in Malawi with pathway to development
30 Mar 2026 - Glen Welham, Co-Founder at Trim Capital, discusses the firm’s initiation of coverage on Chilwa Minerals and the investment case for its Lake Chilwa project.

Chilwa Minerals Ltd (ASX: CHW): Emerging critical minerals play in Malawi
24 Mar 2026 - Chilwa Minerals valued at A$1.53, highlighting upside from critical minerals exposure

Immutep updates market on TACTI-004 and pipeline priorities
19 Mar 2026 - Marc Voigt discusses next steps, data review and upcoming clinical milestones